New chromatography supports must demonstrate improved selectivity, and bead technologies must be optimized for high binding capacity and product recovery. Drug manufacturers also need access to expertise and continued support from chromatography suppliers that can assist with method development and design of experiments (DoE) assessments. Working together, these industry groups can accelerate method development, increase process yield, reduce buffer consumption, minimize the number of unit operations, and improve overall process economies. Learn more in this Special Report about how resin functionalities can maximize yield and improve process economy, helping manufacturers to deliver low-cost biologics to patients with unmet medical needs.
Fill out the form below to read the Special Report and learn more about chromatography resin functionalities now.